| INTRODUCTION
Oral Squamous Cell Carcinoma (OSCC) is the most common cancer in the oral cavity and represents more than 90% of all head and neck cancers. 1 Despite advances in the understanding of the biology of OSCC, the patient survival rate after 5 years is around 50%, mainly due to the presence of regional lymph node metastasis. 2 Like other cancer types, OSCC has a complex tumor microenvironment (TME) with the presence of several stromal cells 3, 4 that might be associated with tumor aggressiveness and the resistance and failure to antineoplastic treatment. 5, 6 Tumor microenvironment is an emerging field in cancer therapy, and it is defined as a complex environment that supports cancer progression, proliferation of neoplastic cells, and invasion of adjacent tissues. It is composed by cancer cells and stromal cells, such as fibroblasts, endothelial cells, pericytes, and immune cells. 7, 8 These cells produce a multitude of molecules with the potential to influence the tumorigenesis process. For instance, cytokines from tumor microenvironment recruit cells from normal adjacent tissues, which are reprogramed to produce various growth factors and other cytokines, and then contribute to tumor cell growth, tissue invasion, metastasis, and, consequently, poor prognosis. 9 Since these cells are linked to the majority of the hallmarks of cancer, 10 researchers have focused on new therapeutic modalities targeted to modulate the behavior of the cellular components of TME. Furthermore, stromal cells do not have mutations like tumor cells, and the changes in cell behavior are modulated by several cytokines expressed in the TME. 7, 10 Among immune cells, tumor-associated macrophages (TAMs) are the most abundant and important stromal cells in the TME. TAMs are considered important players in tumor progression and are related to proliferation and survival of tumor cells, angiogenesis, invasion of surrounding tissues, and metastasis. 11, 12 Furthermore, TAMs' density is related to worse prognosis in several types of cancer. 13 According to stimuli in TME, TAMs can be polarized in two main groups: M1, which is considered proinflammatory and antitumor, and M2, which is considered immunosuppressive and protumor. 16, 19 and release matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-9 and MMP-12) and plasminogen activator urokinase-type (uPA). 20 Herein, we conducted a systematic review to evaluate the influence of macrophages on the prognosis of patients with OSCC. We observed that higher concentrations of TAMs, mainly CD68+ and CD163+, are related to poor prognosis.
2 | ME TH ODS
| Search strategy
The search was performed on PUBMED, SCOPUS, and ISI Web of Knowledge database with the following terms: "head and neck neoplasms" OR "mouth neoplasms" OR "oral squamous cell carcinoma"
OR "head and neck squamous cell carcinoma" OR "head and neck cancer" OR "oral cancer" AND "survival" OR "mortality" OR "prognosis" OR "disease-free survival" OR "survival analysis" AND "macrophage" (the last access was realized on August 2017). Furthermore, searches were done in the references of the selected papers. Two independent authors (AMA e LFD) reviewed the articles, and the studies that generated disagreement between reviewers were reevaluated to be reached on a consensus. PROSPERO registration:
72257.
| Inclusion and exclusion criteria
In this paper, it was included exclusively studies that evaluated the importance of macrophages to the prognosis of the patients with OSCC. Patients in treatment, in vitro and animal models studies, and review articles were excluded.
| Data extraction
Using a standardized instrument, two authors independently extracted the following data: first author, year, sample size, markers, method, median follow-up, evaluated tumor zone, and main results.
| RESULTS
The search in the PUBMED, Web of Science, and Scopus database resulted in 286 articles. Of these, 254 were removed in the title analysis phase: 241 were out of research scope, six were written in a language different than English, and another seven were reviews.
Another 15 studies were declassified by the abstract evaluation: Eight were out of research scope, five analyzed other aspects of macrophages related to OSCC, and two were reviews. After these two steps, it remained 17 works in which the full text was analyzed. At this moment, we discarded three papers due to the analysis of other aspects of macrophages related to OSCC. At the end, 14 studies were included in this review ( Figure 1 ). Table 1 summarizes the demographic and pathological characteristics of the samples from the 14 selected studies, while Table 2 shows the data related to follow-up time, markers, methodology, tumor areas evaluated, and main results.
The publication date of the articles ranged from 2004 to 2017.
The median sample size was 92 patients (range from 17 to 240), and mean age ranged from 51 to 68.9 years. In all studies, tongue was the most common site followed by buccal mucosa, gingiva, and floor of the mouth. And, in relation to smoking and drinking, few studies had this information (Table 1) .
Regarding tumor characteristics, in half of the studies, most of the samples were well differentiated, and the other half were classified as moderate to poor differentiated. Moreover, in most of the studies, tumors were classified as T1/2, N0, and clinical stage 3/4
( Table 1 ).
The median for patient follow-up was 40 months, varying from 18 to 61.5 months. All studies applied immunohistochemistry staining for macrophage markers, and the most used markers in the selected studies were CD68 (panmacrophage antigen, n = 11) and CD163 (M2 macrophage antigen, n = 8). Other three different cell markers were also used in the studies: MRC1 (M2 macrophage antigen, n = 1), CD11b (M2 macrophage antigen, n = 1), and CD11c
(M1 macrophage antigen, n = 1) ( Table 2) .
From the 14 selected articles, only six reported that evaluated different areas of the tumor-the main areas assessed were tumor stroma and tumor epithelium. Two articles related that the higher density of CD68+ or CD163+ or MRC1 macrophages in the epithelial fraction/tumor nest was related to poor outcome. Other two articles related that higher density of CD68+ or CD163+ macrophages in the tumor stroma was related to poor prognosis, and one study showed that the higher density of CD163 in the invasive front of the tumor was associated with worse prognosis. Even in relation to prognosis, all articles evaluated overall survival (OS) followed by disease-free survival (DFS), and one article also evaluated local failure-
free survival (LFFS), distant metastasis-free survival (DMFS), and progression-free survival (PFS). Together, the results of these studies revealed that the increased concentration of TAMs CD68+/ CD163+/MRC1+, depending on the tumor region, was related to worse prognosis. Two papers showed no association between TAMs CD68+ and tumor outcome ( Table 2) . When these altered non-neoplastic cells become malignant cells and invade adjacent connective tissue shortly after basal membrane rupture, there is a switch to an immunosuppressive TME, which allows tumor development. 3, 5 This review included only studies that evaluated the role of macrophages, the main player on TME, in the prognosis of OSCC. The results of the selected studies
| DISCUSSION
showed that a high concentration of macrophages was related to a worse prognosis. Thus, the development of new therapeutic modalities target to TME-related cells might improve the success rate for the treatment of the cancer. 36 Tumor-associated macrophages may be polarized into two different phenotypes: classic M1, which exerts antitumor role; and alternative M2-which exerts protumor role. 11 For M1 macrophages, the most used markers are CD11c, CD80, and HLA-DR, while for M2 detection, it is used CD163, CD11b, CD206, and MRC1. Moreover, it can be used CD68, which is a panmacrophage marker. 11, 13, 14, 24, 31 However, some studies related that CD68 is not specific for macrophages, since fibroblasts and tumor cells might be detected by this marker. 22, 37 From the articles selected for this study, only one used an appropriated marker for M1, 23 and some articles used only the panmacrophage marker CD68. Due to the variability of the data and the methodology of the studies, we did not perform a meta-analysis.
The failure to use specific markers may lead to unspecific findings and does not identify the true role of macrophages in tumor progression and prognosis.
A systematic review conducted by Zhang et al 13 has shown that TAMs are important for the prognosis of patients in different types of solid tumors. In human gastric cancer, it was observed that the higher density of CD68+ macrophage was associated with worse overall survival. 38 In addition, CD68 expression was related to a higher expression of vimentin and low expression of E-cadherin, important markers of epithelial to mesenchyme transition (EMT), suggesting that macrophages can induce EMT. 38 Other study conducted in patients with pancreatic cancer, the presence of M2 macrophages was associated with worse prognosis. 39 The articles selected in this review, except for one, 34 showed association among macrophages, CD68+, CD163+, or MRC1+, and worse prognosis. These findings indicate that the TAMs are important for the prognosis of patients with OSCC.
Although it may be concluded that macrophages -CD68+, CD163+, or MRC1+ -are important for the outcome of OSCC patients, it has not been possible to conclude in which region of the tumor, whether epithelial part, stroma, or invasive front of the tumor, TAMs have more influence on the prognosis. The organization of TME might vary according to the tumor region due to anatomical and biological challenges to the recruitment of stromal cells. 6, 17, 40 In lung cancer, a meta-analysis showed that the infiltration of M2 into the tumor stroma was associated with poor prognosis, while the presence of M1 TAMs into the tumor islands was related to good prognosis. 41 In breast cancer samples, the infiltration of CD68+ macrophages in intratumor compartment 42 or the presence of CD163+ macrophages in the tumor stroma 43 was related with poor prognosis. In the present review, the high density of macrophages CD68+, CD163 or MRC1+ in the epithelial part 22, 23 or the high density of macrophages CD68+ or CD163+ in tumor OS, overall survival; DFS, disease-free survival; LFFS, local failure-free survival; DMFS, distant metastasis-free survival; PFS, progression-free survival; IHC, immunohistochemistry; NR, not reported; CD68, panmacrophage marker; CD163, CD11b, and MRC1, M2 macrophage; CD11c, M1 macrophage.
P-value and confidence interval are related to univariate analysis.
a Poor outcome = occurrence of local recurrence, a second oral tumor, lymph node metastasis or distant metastasis during the follow-up period.
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| 465 stroma 24, 27 was related with worse prognosis. In addition, one study 26 showed that high density of macrophages CD163+ in invasive front of the OSCC was related with worse prognosis. These data show the relevance of assessing not only the polarization of the macrophages, but also the zone of the tumor where it is present.
Since macrophages show dynamic plasticity within TME that could result in pro-or antitumor activity, we suggest studies with the use of specific markers for the detection of M1 (CD11c, CD80 and HLA-DR) or M2 (CD163, CD11b, CD206 and MRC1) TAMs at different regions of patient biopsies. With this approach, the association of M1 or M2 with prognosis will be more precise, corroborating for the development of therapeutic strategies that targets the polarization reprograming of these cells. Also, analysis of TAMs at the epithelia adjacent to tumor will contribute to a better understanding of the role of TAM within TME and its potential role in tumor recurrence.
One of the main causes of decreased survival in cancer patients is related to the development of metastasis. Besides the modulation of the tumor cell migration performance, 44 components of TME might contribute to the preparation of the pre-metastatic niche. 8, 45 It was demonstrated in cancer that TAMs contribute to the formation of the pre-metastatic niche by releasing molecules that promote angiogenesis as well as the chemoattraction of tumor cells and naive macrophages to the local of metastasis. 45 In an in vitro study with triple negative breast cancer, it was demonstrated that the metastatic suppressors reduce the macrophage infiltration in the tumor and consequently decreased metastasis. 46 For OSCC, patients with metastasis in lymph nodes exhibited high infiltration of M2 macrophages both in the tumor and in the lymph node. 47 Based on these results, it is possible that TAMs not only participate in the invasive process of tumor cells, but also modify the pre-metastatic niche to receive the metastatic cells.
The present review showed that macrophages are important components of OSCC-TME, and M2 TAMs are related with worse overall survival and disease-free survival. Nevertheless, it was not possible to identify in which tumor zone the presence of these cells are more relevant to prognosis, being necessary other studies that evaluate the characteristics of TAMs, whether M1 or M2, and in which region of the TME is more relevant to the outcome.
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